World’s Only Hygienic Digital Urine Test Launched
By LabMedica International staff writers Posted on 28 Jan 2019 |

Image: The Urine Testing System has been designed to improve the entire process from receiving the sample and recording results, to analysis in the laboratory (Photo courtesy of Clinical Design).
The world’s only hygienic, easy-to-use and accurate digital point-of-care urine test named Urine Testing System was launched at Arab Health 2019 by Clinical Design (Penryn, Cornwall, UK). The digital point-of-care urine test has been designed to improve the entire process from receiving the sample and recording results, to analysis in the laboratory.
The highly intuitive system features sealed, leak-proof samples, automatically timed readings and the ability to save digital results directly into the patient’s electronic health record. No decanting is required, reducing the risk of contamination and false positive samples being sent to laboratories. Digital readings are also more accurate compared to manual urinalysis as they eliminate variation in subjective analysis and the risk of error during manual recording.
Urine Testing System works seamlessly as a closed integrated system and includes a patented, single-use cap containing reagent pads to test ten parameters: leukocytes, nitrite, urobilinogen, protein, pH, blood, specific gravity, ketone, bilirubin and glucose. Once the patient has collected the urine sample, the healthcare professional simply connects UTS-10 Cap; creating a sealed, leak-proof module. This UTS module is then loaded into the UTS Digital Analyzer and the automatically timed, digital results are shown on the integrated LCD screen or in the UTS Desktop Software if connected to a computer.
The sample can be disposed of in clinical waste or be sent to the laboratory with no need to decant. It is specially designed to fit in standard laboratory racking – and can be purchased with or without boric acid depending on laboratory requirements. The current test takes approximately one to two minutes and risks include spillage of a contaminated sample, as well as human errors during analysis and/or the manual recording into a patient's records.
“We have developed a simple integrated system that increases the efficacy of patient point-of-care urine testing and improves first-time diagnosis. It is the only closed urine testing system available anywhere in the world and we are delighted to be able to showcase it at Arab Health 2019,” said Oliver Blackwell, CEO of Clinical Design.
Related Links:
Clinical Design
The highly intuitive system features sealed, leak-proof samples, automatically timed readings and the ability to save digital results directly into the patient’s electronic health record. No decanting is required, reducing the risk of contamination and false positive samples being sent to laboratories. Digital readings are also more accurate compared to manual urinalysis as they eliminate variation in subjective analysis and the risk of error during manual recording.
Urine Testing System works seamlessly as a closed integrated system and includes a patented, single-use cap containing reagent pads to test ten parameters: leukocytes, nitrite, urobilinogen, protein, pH, blood, specific gravity, ketone, bilirubin and glucose. Once the patient has collected the urine sample, the healthcare professional simply connects UTS-10 Cap; creating a sealed, leak-proof module. This UTS module is then loaded into the UTS Digital Analyzer and the automatically timed, digital results are shown on the integrated LCD screen or in the UTS Desktop Software if connected to a computer.
The sample can be disposed of in clinical waste or be sent to the laboratory with no need to decant. It is specially designed to fit in standard laboratory racking – and can be purchased with or without boric acid depending on laboratory requirements. The current test takes approximately one to two minutes and risks include spillage of a contaminated sample, as well as human errors during analysis and/or the manual recording into a patient's records.
“We have developed a simple integrated system that increases the efficacy of patient point-of-care urine testing and improves first-time diagnosis. It is the only closed urine testing system available anywhere in the world and we are delighted to be able to showcase it at Arab Health 2019,” said Oliver Blackwell, CEO of Clinical Design.
Related Links:
Clinical Design
Latest MEDLAB 2019 News
- ERBA Group Launches New Hematology Analyzers at MEDLAB 2019
- Telstar Promotes Latest Generation of Freeze Dryers in Dubai
- Siemens Healthineers Showcases In-Vitro Diagnostics Products at MedLab 2019
- Randox Promotes Evidence MultiSTAT Automated Benchtop Immunoassay Analyzer
- Mindray Displays New Generation Benchtop Cellular Analysis Line
- HORIBA Medical Shows Latest Yumizen G Range at Lab Trade Show
- Greiner Bio-One Displays Range of Safety Products at MedLab
- EKF Diagnostics Presents Latest Diabetes Care Analyzers
- BioSystems Highlights New iFOB Integral System at MedLab 2019
- Beckman Coulter Exhibits New Hematology Analyzer in Middle East
- Agappe Diagnostics Displays Analyzers and Solutions at Middle East Congress
- Abbott Highlights Point of Care Management Solutions
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia
A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more
New Technique for Measuring Acidic Glycan in Blood Simplifies Schizophrenia Diagnosis
Polysialic acid is a unique acidic glycan predominantly found in brain regions associated with memory and emotion, but it is also present in the bloodstream. Research has shown that blood levels of polysialic... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Performs Virtual Tissue Staining at Super-Resolution
Conventional histopathology, essential for diagnosing various diseases, typically involves chemically staining tissue samples to reveal cellular structures under a microscope. This process, known as “histochemical... Read more
AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis
Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read moreTechnology
view channel
Inexpensive DNA Coated Electrode Paves Way for Disposable Diagnostics
Many people around the world still lack access to affordable, easy-to-use diagnostics for diseases like cancer, HIV, and influenza. Conventional sensors, while accurate, often rely on expensive equipment... Read more
New Miniature Device to Transform Testing of Blood Cancer Treatments
Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for blood cancers like leukemia, offering hope to patients when other treatments fail. However, despite its promise,... Read moreIndustry
view channel
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more